Retrospective analysis of survival improvement by molecular biomarker-based personalized chemotherapy for recurrent ovarian cancer.

PLoS One · 2014 · PMC3914805 · PMID 24505259

Europe PMC DOI

hedged sentences

0.0030

closest p · 0.1× alpha

0.0750

boldest claim

The sentences

highly significantp-value = 0.003actually significant

In our univariate logistic regression analysis for each of the predictors and clinical variables, a highly significant difference was found between the two patient groups in TCGA-448 (p-value = 0.003).

also in 132,142 other papers

marginally significantp-value = 0.075so close (0.05 < p ≤ 0.1)

For the UVA-51 cohort, paclitaxel predictor scores showed a marginally significant difference between 28 CR and 23 NR patients due to its relatively small sample size (p-value = 0.075, left column in Table 2 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.